| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |